```html

Valve Disease (Heart) – Comprehensive Medical Guide

Overview

Heart valve disease (also called valvular heart disease) occurs when one or more of the four cardiac valves – the aortic, mitral, pulmonary, or tricuspid – do not open or close properly. This can lead to:

• Blood flow obstruction (stenosis) – the valve is too narrow.
• Regurgitation (insufficiency) – the valve leaks, allowing blood to flow backward.

Both conditions force the heart to work harder, eventually causing enlargement, reduced pumping ability, and heart failure if left untreated.

Who is affected?

Valve disease can affect anyone, but the most common patterns are:

• Age‑related degeneration: Calcific aortic stenosis is rare before age 60 but affects ~2% of people >65 years and 12% of those >80 years (Mayo Clinic, 2023).
• Congenital abnormalities: Bicuspid aortic valve occurs in 1–2 % of newborns, predominantly males.
• Rheumatic fever: Still a leading cause of mitral valve disease in low‑ and middle‑income countries, affecting ~15 million people worldwide (WHO, 2022).

Prevalence

In the United States, ≈2.5 million adults have clinically significant valve disease, and an additional 13 million have mild or moderate disease that may progress over time (American Heart Association, 2022). Prevalence rises sharply after age 70, making valve disease one of the most common cardiac conditions in the elderly.

Symptoms

Many people with early valve disease are asymptomatic. When symptoms appear, they often worsen gradually.

• Shortness of breath (dyspnea): Especially on exertion or when lying flat (orthopnea).
• Fatigue & weakness: Due to reduced cardiac output.
• Chest pain or tightness (angina): Common with aortic stenosis when the heart muscle is strained.
• Palpitations: Irregular or rapid heartbeat from atrial enlargement.
• Swelling (edema): In the ankles, feet, or abdomen, indicating right‑sided heart failure.
• Syncope or near‑syncope: Brief fainting episodes, especially during activity (red flag for severe aortic stenosis).
• Heart murmur: A sound heard by a clinician during auscultation; not a symptom but a key diagnostic clue.
• Reduced exercise tolerance: Trouble climbing stairs or walking a short distance.
• Nighttime cough or wheezing: From pulmonary congestion.

Causes and Risk Factors

Primary Causes

• Degenerative calcification: Calcium deposits thicken and stiffen valve leaflets, most often the aortic valve.
• Rheumatic fever: An autoimmune reaction after a Group A streptococcal infection can scar valve leaflets, especially the mitral valve.
• Congenital malformations: Bicuspid aortic valve, atrial septal defect–related valve changes, etc.
• Infective endocarditis: Bacterial infection damages valve tissue, leading to regurgitation or perforation.
• Radiation therapy: Chest irradiation (e.g., for Hodgkin lymphoma) accelerates valve fibrosis.

Risk Factors

• Age > 60 years (degenerative disease)
• Male sex (higher incidence of aortic stenosis & bicuspid valve)
• Hypertension & hyperlipidemia (promote calcification)
• Smoking (accelerates atherosclerotic and valvular calcification)
• History of rheumatic fever or untreated streptococcal throat infection
• Chronic kidney disease – associated with calcium‑phosphate metabolism disturbances
• Family history of congenital valve anomalies
• Previous chest radiation

Diagnosis

Diagnosis begins with a careful history and physical exam, followed by imaging and sometimes invasive testing.

Physical Examination

• Auscultation of a murmur – timing (systolic vs. diastolic) and quality help identify the affected valve.
• Signs of heart failure: peripheral edema, displaced apical impulse, jugular venous distention.

Imaging & Tests

1. Transthoracic echocardiogram (TTE): First‑line, non‑invasive test that visualizes valve structure, measures gradients, and assesses chamber size. Sensitivity > 90 % for moderate‑severe disease (ACC/AHA guideline 2020).
2. Transesophageal echocardiogram (TEE): Provides higher resolution, useful for prosthetic valve assessment or endocarditis.
3. Cardiac MRI: Quantifies regurgitant volume and evaluates myocardial fibrosis.
4. CT scan: Determines calcium burden in aortic stenosis; helps plan transcatheter aortic valve replacement (TAVR).
5. Electrocardiogram (ECG): Detects atrial fibrillation, conduction delays, or ventricular hypertrophy.
6. Cardiac catheterization: Invasive pressure measurements when non‑invasive studies are inconclusive or before surgery.
7. Blood tests: BNP/NT‑proBNP (heart failure severity), CBC & cultures (if endocarditis suspected), renal & liver function.

Treatment Options

Management depends on valve type, severity, symptoms, and patient comorbidities.

Medications

• Diuretics: Reduce fluid overload in heart failure.
• Beta‑blockers & ACE inhibitors/ARBs: Lower heart‑rate and afterload, helpful in regurgitant lesions with ventricular dysfunction.
• Anticoagulation: Warfarin or direct oral anticoagulants for atrial fibrillation, mechanical prosthetic valves, or certain forms of endocarditis.
• Antibiotic prophylaxis: Prior to dental or invasive procedures for patients with prosthetic valves or prior infective endocarditis (per AHA 2023).

Procedural Interventions

1. Valve Repair: Preferred when feasible (e.g., mitral valve prolapse repair) because it preserves native tissue.
2. Valve Replacement:
   • Surgical (SAVR/TAVR): Mechanical or bioprosthetic valves implanted via open‑heart surgery.
   • Transcatheter (TAVR, MitraClip, Transcatheter Mitral Valve Replacement): Minimally invasive, especially for high‑risk surgical candidates.
3. Balloon Valvuloplasty: Temporary dilation of stenotic valves; most useful in rheumatic mitral stenosis or in critically ill patients awaiting definitive surgery.
4. Percutaneous Closure of Paravalvular Leak: For residual leaks after valve replacement.

Lifestyle & Supportive Measures

• Regular aerobic activity (as tolerated) – 150 min/week of moderate‑intensity exercise improves functional capacity.
• Low‑sodium diet (<2 g/day) to prevent fluid overload.
• Weight management – aim for BMI 18.5–24.9 kg/m².
• Smoking cessation and moderation of alcohol intake.
• Vaccinations: Influenza, pneumococcal, and COVID‑19 to reduce infection‑related cardiac stress.

Living with Valve Disease (Heart)

Daily Management Tips

• Medication adherence: Use pill organizers or smartphone reminders; never stop a drug without consulting your cardiologist.
• Symptom tracking: Keep a log of dyspnea, fatigue, weight changes, and any episodes of palpitations or fainting.
• Fluid balance: If advised, restrict fluid intake to <2 L/day; monitor daily weight.
• Regular follow‑up: Echocardiograms every 1–2 years for mild disease, every 6‑12 months for moderate/severe lesions.
• Exercise guidance: Start with low‑impact activities (walking, stationary bike) and progress under supervision. Avoid high‑intensity or isometric exercises if you have severe stenosis or recent syncope.
• Dental hygiene: Brushing and flossing daily; see a dentist regularly. Notify dentist of your valve status for prophylactic antibiotics if needed.
• Travel considerations: Carry copies of your cardiac records, medication list, and a letter from your physician detailing valve disease and any required emergency treatments.

Emotional & Social Support

Living with a chronic heart condition can be stressful. Consider:

• Joining patient support groups (e.g., American Heart Association “Heart Valve Support”).
• Speaking with a mental‑health professional if anxiety or depression develops.
• Educating family members about warning signs and medication schedules.

Prevention

While congenital and rheumatic causes cannot always be prevented, many risk factors are modifiable.

• Control blood pressure and cholesterol: Target <130/80 mm Hg and LDL < 100 mg/dL (or as individualized).
• Quit smoking: Reduces calcific progression; resources include nicotine‑replacement therapy and counseling.
• Manage diabetes: Tight glycemic control (<7 % HbA1c) lowers cardiovascular complications.
• Prompt treatment of streptococcal throat: Antibiotic therapy (penicillin) prevents rheumatic fever.
• Regular cardiovascular screening: Especially for individuals > 60 years or with a family history of valve disease.
• Limit excessive calcium supplementation in patients with chronic kidney disease to avoid accelerated valve calcification.

Complications

If left untreated, valve disease can progress to serious complications:

• Heart failure: Reduced ejection fraction or preserved‑EF dysfunction.
• Atrial fibrillation: Common with mitral stenosis or regurgitation due to left‑atrial enlargement.
• Endocarditis: Damaged valve surfaces are prone to bacterial colonization.
• Thromboembolism: Especially with prosthetic valves or atrial fibrillation, increasing stroke risk.
• Pulmonary hypertension: From chronic left‑sided pressure overload.
• Sudden cardiac death: Rare but possible when severe aortic stenosis limits coronary flow during exertion.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

• Sudden, severe chest pain or pressure that does not improve with rest.
• New or worsening shortness of breath at rest or with minimal activity.
• Fainting, near‑fainting, or sudden loss of consciousness.
• Rapid, irregular heartbeat accompanied by dizziness or weakness.
• Sudden swelling of the legs, abdomen, or rapid weight gain (> 2 kg in 24 hr).
• High fever, chills, and a new heart murmur – possible infective endocarditis.

These symptoms may indicate acute decompensation, severe valve obstruction, or life‑threatening arrhythmia.

References

• American College of Cardiology / American Heart Association. 2020 Guideline for the Management of Valvular Heart Disease. Circulation. 2020.
• Mayo Clinic. “Aortic stenosis.” Updated 2023. https://www.mayoclinic.org
• World Health Organization. “Rheumatic heart disease.” 2022. https://www.who.int
• National Institutes of Health, National Heart, Lung, and Blood Institute. “Heart Valve Disease.” 2023. https://www.nhlbi.nih.gov
• Cleveland Clinic. “Mitral Valve Regurgitation.” 2022. https://my.clevelandclinic.org
• Centers for Disease Control and Prevention. “Rheumatic Fever and Rheumatic Heart Disease.” 2023. https://www.cdc.gov

```